Jesse D Deere Selected Research

ogalvibart

1/2021

Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jesse D Deere Research Topics

Disease

11	Infections 01/2022 - 01/2011
5	COVID-19 01/2022 - 07/2020
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2016 - 03/2010
2	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Viremia 01/2020 - 07/2010
1	Inflammation (Inflammations) 12/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Persistent Infection 01/2019
1	Reinfection 01/2019
1	Cytomegalovirus Infections (Inclusion Disease) 01/2018
1	Virus Diseases (Viral Diseases) 07/2014

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 07/2020 - 01/2016
5	Neutralizing AntibodiesIBA 01/2022 - 02/2013
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
2	AntibodiesIBA 01/2021 - 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	ogalvibartIBA 01/2021
1	crexavibartIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	InterferonsIBA 07/2020
1	CytokinesIBA 07/2020
1	AntigensIBA 01/2020
1	retanefIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Butyrates (Butyrate)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 07/2014
1	Proteins (Proteins, Gene)FDA Link 02/2013
1	Glycoproteins (Glycoprotein)IBA 02/2013
1	Viral RNAIBA 07/2010

Therapy/Procedure

2	Immunotherapy 01/2022 - 09/2021
2	Therapeutics 09/2021 - 01/2011
2	Highly Active Antiretroviral Therapy (HAART) 07/2010 - 03/2010